Crossmark

Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients

Crossref DOI link: https://doi.org/10.1007/s40123-022-00550-7

Published Online: 2022-07-29

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Siying

Tang, Jiyang

Han, Xinyao

Wang, Zongyi

Zhang, Linqi

Zhao, Mingwei

Qu, Jinfeng https://orcid.org/0000-0001-9975-1602
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct05408416 at ClinicalTrials.gov

Documents that mention this clinical trial

Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients
https://doi.org/10.1007/s40123-022-00550-7
Funding

Funding for this research was provided by:

Capital Clinical Diagnosis and Treatment Technology Research and Demonstration Application Project of China (Z191100006619029)

National Key R&D Program of China (2020YFC2008200)
License Information

Text and Data Mining valid from 2022-07-29

Version of Record valid from 2022-07-29
More Information

Article History

Received: 8 June 2022

Accepted: 7 July 2022

First Online: 29 July 2022

Document is current

Any future updates will be listed below